3,4-dihydroxyphenylglycol has been researched along with Fatigue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
deAndrés-Galiana, EJ; Feng, LR; Fernández-Martínez, JL; Saligan, LN; Wolff, BS; Zaal, KJM | 1 |
Boraxbekk, CJ; Dempsey, PC; Dunstan, DW; Eikelis, N; Ellis, KA; Hernestål-Boman, J; Howard, B; Lambert, G; Larsen, R; Occleston, J; Owen, N; Sethi, P; Wennberg, P; Wheeler, M | 1 |
1 trial(s) available for 3,4-dihydroxyphenylglycol and Fatigue
Article | Year |
---|---|
Acute effects of breaking up prolonged sitting on fatigue and cognition: a pilot study.
Topics: Aged; Blood Glucose; Blood Pressure; Cognition; Cross-Over Studies; Dihydroxyphenylalanine; Fatigue; Female; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Obesity; Overweight; Pilot Projects; Sedentary Behavior; Walking | 2016 |
1 other study(ies) available for 3,4-dihydroxyphenylglycol and Fatigue
Article | Year |
---|---|
mGluR5 mediates post-radiotherapy fatigue development in cancer patients.
Topics: Aged; Fatigue; Genome-Wide Association Study; Humans; Jurkat Cells; Machine Learning; Male; Methoxyhydroxyphenylglycol; Middle Aged; NF-kappa B; Prostatic Neoplasms; Pyridines; Radiotherapy; Radiotherapy Dosage; Receptor, Metabotropic Glutamate 5; T-Lymphocytes; Transcriptome | 2018 |